8.52Open8.52Pre Close0 Volume0 Open Interest60.00Strike Price0.00Turnover112.49%IV-2.10%PremiumJan 17, 2025Expiry Date9.58Intrinsic Value100Multiplier4DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9112Delta0.0262Gamma5.14Leverage Ratio-0.1006Theta-0.0053Rho-4.69Eff Leverage0.0089Vega
ABM Industries Stock Discussion
$Pfizer (PFE.US)$ — The biopharmaceutical stock dropped 7.4% after Pfizer issued full-year guidance for adjusted earnings ...
Gapping up
$Adobe (ADBE.US)$ stock rose 1.6% after Mizuho Securities upgraded the computer software company to ‘buy’ from ‘neutral’, saying it is well-positioned to capitalize on digital transformation with its highly comprehensive end-to-end offering.
$DocuSign (DOCU.US)$ stock rose 1% after the e-signature company beat expectations in its second quarter, with revenue up 10.5% year-on-year, and thu...
$Delta Air Lines (DAL.US)$ 3.8% (the airline raised its current quarter forecast and issued an upbeat 2023 outlook, citing robust travel demand.)
$Moderna (MRNA.US)$ +1.6% (The Tuesday advance followed a successful study of a skin cancer treatment involving an experimental Moderna vaccine in combination with $Merck & Co (MRK.US)$ cancer drug Keytruda.
$Aspen Group (ASPU.US)$ +14.8% (the online education company reported better-...
On Tuesday morning, the Bureau of Labor Statistics will report the November Consumer Price Index. The Federal Open Market Committee concludes a two-day meeting on Wednesday afternoon. Markets are expecting an increase of 0.5 percentage point in...
• $ABM Industries (ABM.US)$ : Baird Upgrades to Outperform from Neutral - PT $50
• $American Tower Corp (AMT.US)$ : JPMorgan Upgrades to Overweight from Underweight - PT $285 (from $245)
• $Church & Dwight (CHD.US)$ : Wells Fargo Upgrades to Overweight from Equal Weight - PT $95
• $Chewy (CHWY.US)$ : Wedbush Upgrades to Outperform from Neutral - PT $35 (from $30)
• $Centene (CNC.US)$ : Credit Suisse Upgrades to Outperform from...
• $Signet Jewelers (SIG.US)$ +7.6% (In reaction to earnings/guidance)
• $Oxford Industries (OXM.US)$ +6.3% (In reaction to earnings/guidance)
• $BridgeBio Pharma (BBIO.US)$ +5%(to Present Phase 2b Data and Pivotal Phase 3 Study Design of Encaleret in Autosomal Dominant Hypocalcemia Type 1 (ADH1) at the Endocrine Society (ENDO) 2022 Annual Conference)
• $Greif (GEF.US)$ +4.6% (In reaction to earnings/guidance)
• $Olema Pharmaceuticals (OLMA.US)$ +4.3% (an...
No comment yet